NBIX ▲ +0.0% - Neurocrine Biosciences, Inc.
$NBIX - Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia
16-OCT-2026 08:30 AM ET
Share this post
More filings for $NBIX
NBIX - Neurocrine Biosciences, Inc. - SEC Filing Update (15-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 15, 2026NBIX ▼ -0.7% - Neurocrine Biosciences, Inc.Oct 12, 2026NBIX ▼ -0.3% - Neurocrine Biosciences, Inc.Sep 30, 2026$NBIX SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $NBIX filing history →💬 Comments
Loading comments…
Leave a comment